Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Transcept names John Kollins SVP and CBO

This article was originally published in Scrip

Executive Summary

Transcept Pharmaceuticals, a specialty pharmaceutical company focused on the development of products that address therapeutic needs in neuroscience, has appointed John Kollins senior vice-president and chief business officer, reporting to Glenn Oclassen, president and CEO of Transcept. Prior to joining Transcept, Mr Kollins provided strategy, business development and transaction services to life science companies via Parnassus Advisors, the consulting and advisory firm he established.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts